BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Return 22.5%
This Quarter Return
+3.37%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$957M
AUM Growth
+$1.08M
Cap. Flow
-$8.63M
Cap. Flow %
-0.9%
Top 10 Hldgs %
32.99%
Holding
140
New
9
Increased
34
Reduced
55
Closed
6

Top Buys

1
DXCM icon
DexCom
DXCM
$12.7M
2
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$10.1M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
$9.58M
4
INCY icon
Incyte
INCY
$8.07M
5
CELG
Celgene Corp
CELG
$7.5M

Top Sells

1
AMGN icon
Amgen
AMGN
$20.3M
2
GILD icon
Gilead Sciences
GILD
$15.9M
3
ABMD
Abiomed Inc
ABMD
$10.9M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$8.6M
5
ABBV icon
AbbVie
ABBV
$8.05M

Sector Composition

1 Healthcare 95.72%
2 Financials 0.41%
3 Industrials 0.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MDCO
126
DELISTED
Medicines Co
MDCO
$488K 0.05%
17,850
-1,650
-8% -$45.1K
EVHC
127
DELISTED
Envision Healthcare Holdings Inc
EVHC
$450K 0.05%
13,026
– –
MYGN icon
128
Myriad Genetics
MYGN
$621M
$412K 0.04%
12,000
-1,000
-8% -$34.3K
AAC
129
DELISTED
AAC Holdings, Inc.
AAC
$405K 0.04%
45,000
– –
SGRY icon
130
Surgery Partners
SGRY
$2.88B
$375K 0.04%
31,000
– –
ALDR
131
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$350K 0.04%
30,600
-2,400
-7% -$27.5K
ACHC icon
132
Acadia Healthcare
ACHC
$2.16B
$326K 0.03%
10,000
-21,000
-68% -$685K
HIND
133
Vyome Holdings, Inc. Common Stock
HIND
$222M
– –
0
– -$457K
TBPH icon
134
Theravance Biopharma
TBPH
$702M
$296K 0.03%
10,628
-3,800
-26% -$106K
CLDX icon
135
Celldex Therapeutics
CLDX
$1.51B
– –
-10,667
Closed -$458K
IQV icon
136
IQVIA
IQV
$30.8B
– –
-71,170
Closed -$6.77M
ADMS
137
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
– –
-24,000
Closed -$508K
MNK
138
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-229,983
Closed -$8.6M
CEMP
139
DELISTED
Cempra, Inc.
CEMP
– –
-165,000
Closed -$536K
BCR
140
DELISTED
CR Bard Inc.
BCR
– –
-22,740
Closed -$7.29M
2 3 4 5
6